Adiponectin has been implicated in the pathogenesis of HIV– associated lipodystrophy[12], with PI administration in mice producing a dose-related reduction in adiponectin levels and administration of recombinant adiponectin ameliorating the associated dyslipidaemia. The gene discussed is ADIPOQ; the disease is lipodystrophy.